Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE) (ACE)
HIV Medication Adherence, Methamphetamine Use, Sexual Risk

About this trial
This is an interventional treatment trial for HIV Medication Adherence focused on measuring Medication Adherence, Methamphetamine Use, Sexual Risk, Poly-substance Use, HIV, Treatment, Motivational Interviewing, Cognitive Behavioral Skills Training, Men Who Have Sex With Men
Eligibility Criteria
Inclusion Criteria:
- HIV+ (confirmed at baseline through documentation)
- Biologically male
- report sex with another man at least once
- report methamphetamine use at least three times in the past three months
- report less than 90% HAART medication adherence, as measured by the total number of days a participant missed an HIV medication in the last 30
- able to communicate with staff and complete a survey that is in English.
Exclusion Criteria:
- Unstable, serious psychiatric symptoms
- Currently suicidal/homicidal
- Evidence of gross cognitive impairment
- Self-reported current enrollment in a drug or HIV-related intervention or research study.
- Methadone use
Sites / Locations
- Center for HIV/AIDS Educational Studies and Training of Hunter College, CUNY
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Intervention Condition
Education Condition
Eight sessions of Motivational Interviewing and Cognitive Behavioral Skills Training, adapted to target both MA use and medication adherence, as well as sexual risk behaviors and polydrug use.
Eight sessions of education with content designed to mirror the information covered in the intervention condition. The content will be as follows: 3 sessions focusing on medication adherence; 3 sessions focusing on the dangers of methamphetamine use; 1 session addressing sexual risk; and 1 session addressing poly-substance use.